Targeting VDR-RXR heterodimerization in neurodegenerative diseases: a hypothetical framework for combined vitamin D&lt;sub&gt;3&lt;/sub&gt; and vitamin A therapy. The gene discussed is VDR; the disease is neurodegenerative disease.